| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $290.5M | +473.0% |
| R&D Expense | $53.6M | +15.4% |
| SG&A Expense | $113.7M | +15.5% |
| Operating Income | $65.7M | +159.9% |
| Pre-tax Income | $95.4M | +639.4% |
| Income Tax | $6.2M | +215.4% |
| Net Income | $89.2M | +715.6% |
| EPS (Basic) | $3.12 | +680.0% |
| EPS (Diluted) | $3.00 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $344.9M | -3.8% |
| Accounts Receivable | $104.7M | +149.2% |
| Inventory | $26.5M | +279.5% |
| Current Assets | $742.0M | +26.2% |
| Total Assets | $1.06B | +29.0% |
| Current Liabilities | $102.0M | +208.2% |
| Total Liabilities | $109.5M | +175.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $123.4M | +239.0% |
| Capital Expenditures | $4.2M | -64.1% |
| Investing Cash Flow | -$163.4M | -297.8% |
| Financing Cash Flow | $27.0M | -86.7% |
| Free Cash Flow | $119.2M | +218.5% |
| +669.2% |
| Stockholders' Equity |
| $946.4M |
| +21.5% |